title: HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital.
abstract: In an exercise to study the immunogenicity and reactogenicity of the Engerix B vaccine, 160 medical students were screened for Hepatitis B Markers (HBsAg, HBsAb and HBcAb) with a view to vaccinating those that were negative. 18% were HBsAg + ve, 33% were HBsAb + ve and 38% were positive for the HBcAb. These figures were extremely high and obviated the need to vaccinate the students as they begin their clinical years.
authors: G N
authors: GN
authors: Lule
authors: F
authors: F
authors: Okoth
authors: E O
authors: EO
authors: Ogutu
authors: S J
authors: SJ
authors: Mwai
mesh_terms: D002353:Carrier State / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D015994:Incidence; D007630:Kenya; D008297:Male; D013337:Students, Medical
chemical_list: D006514:Hepatitis B Surface Antigens